LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
LENSAR, Inc.NASDAQ: LNSR
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) growth accelerates
Q1 FY2026 weighted avg shares (diluted) of 15.42M shares rose 31.0% year over year, ahead of the +10.8% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 27.7% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +31.0% holds above the trailing-twelve-month pace of +10.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 11.96M USD
- Year-over-year change
- +3.8%
- 4-year CAGR
- +6.3%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.96M | +3.8% |
| FY2024 | 2024-12-31 | 11.52M | +5.0% |
| FY2023 | 2023-12-31 | 10.97M | +8.0% |
| FY2022 | 2022-12-31 | 10.16M | +8.4% |
| FY2021 | 2021-12-31 | 9.37M | — |
Weighted Avg Shares (Diluted) vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 weighted avg shares (diluted) of 12.87M shares is the 9th highest of the 10 companies compared; the peer median is 43.78M shares.
- Its year-over-year change of +10.8% is the 6th highest of 10, against a peer median of +21.2%.
- Over three fiscal years its annual growth of +5.6% compares with a peer median of +8.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 149.39M | +1085.6% | +313.6% | |
| LTM Mar 2026 | 106.51M | +1.3% | +1.5% | |
| LTM Mar 2026 | 67.15M | +43.6% | +15.3% | |
| LTM Mar 2026 | 44.81M | +2.4% | +1.7% | |
| LTM Mar 2026 | 43.78M | +66.1% | +8.6% | |
| LTM Mar 2026 | 31.8M | +21.2% | +13.2% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | 23.58M | -20.8% | -13.1% |
| LTM Mar 2026 | 14.25M | -2.8% | -0.5% | |
| LTM Mar 2026 | 12.87M | +10.8% | +5.6% | |
| LTM Mar 2026 | 12.8M | +30.5% | +47.3% | |
| Peer median (excluding LNSR) | 43.78M | +21.2% | +8.6% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.